--- title: "3SBIO rose 10.25% in half a day, distributing all shares of Mandi International" type: "News" locale: "en" url: "https://longbridge.com/en/news/281301030.md" description: "3SBIO opened high today at 3.36%, closing up 10.25% at 24.96 yuan, with a trading volume of 38.3572 million shares and a total transaction value of 922 million yuan. The company announced that it will distribute all of its shares in Mandi International to eligible shareholders through a physical distribution method. Mandi International is a professional consumer pharmaceutical company focused on skin health and weight management" datetime: "2026-04-01T04:25:23.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281301030.md) - [en](https://longbridge.com/en/news/281301030.md) - [zh-HK](https://longbridge.com/zh-HK/news/281301030.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281301030.md) | [繁體中文](https://longbridge.com/zh-HK/news/281301030.md) # 3SBIO rose 10.25% in half a day, distributing all shares of Mandi International 3SBIO (01530.HK) distributed all shares of Mandi International in kind, opening up 3.36% today, with a peak at 25 HKD. It closed at 24.96 HKD at noon, up 10.25%, with a trading volume of 38.3572 million shares, involving 922 million HKD. 3SBIO announced that it will distribute a special dividend in kind, distributing all shares of Mandi held by the company to eligible shareholders in proportion to their holdings before the proposed spin-off is completed. The company announced the proposed spin-off of Mandi International shares last November and plans to list independently on the main board of the Hong Kong Stock Exchange. Currently, the company holds an 87.16% stake in Mandi International, which is a professional consumer pharmaceutical company dedicated to developing and providing comprehensive and long-term solutions in the fields of skin health and weight management. (ad/) ### Related Stocks - [3SBIO (01530.HK)](https://longbridge.com/en/quote/01530.HK.md) - [蔓迪国际 (25325.HK)](https://longbridge.com/en/quote/25325.HK.md) ## Related News & Research - [3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady](https://longbridge.com/en/news/281054154.md) - [A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal](https://longbridge.com/en/news/281030969.md) - [3SBio Seeks HK$3.12 Billion via Share Sale](https://longbridge.com/en/news/268172267.md) - [Cricket League minigame comes to BGMI: How to win M416 Glacier skin, more](https://longbridge.com/en/news/280610251.md) - [16:49 ETBiohacking Beauty Routines Gain Traction as Clients Seek Smarter, Data-Informed Skincare Approaches](https://longbridge.com/en/news/280845183.md)